China’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO push

Oricell Therapeutics has now raised over $100 million in its final funding round before the Chinese CAR-T therapy biotech seeks to go public. The Shanghai-based company secured backing from the likes …
( read original story …)

---